Context Therapeutics Inc. financial statements
Context Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 36.12M | 10-K |
| Cash and equivalents | USD 66M | 10-Q |
| Total debt | USD 112.06K | EODHD |
Context Therapeutics Inc. financials on 6ix · Context Therapeutics Inc. on 6ix